Effects of empagliflozin on exercise tolerance and left ventricular diastolic function in patients with heart failure with preserved ejection fraction and type 2 diabetes: a prospe... by A. G. Ovchinnikov, A. A. Borisov, K. Yu. Zherebchikova, O. Yu. Ryabtseva, A. D. Gvozdeva, V. P. Masenko, F. T. Ageev, S. A. Boytsov

“…To assess the effect of the sodium-glucose transport protein 2 inhibitor empagliflozin on exercise tolerance and left ventricular (LV) diastolic function in patients with heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes (T2D).Material and methods. …”
Get full text

Left Dominant Coronary Circulation is Associated with Poorer Left Ventricular Function but Not Long-Term Mortality After ST Elevation Myocardial Infarction by Yusuf Bozkurt Şahin, Emrullah Kızıltunç, Salih Topal, Adnan Abacı

“…Conclusion: Patients with left dominance had significantly lower left ventricular systolic function early after STEMI. …”
Get full text

Tale of three services: early UK experience with mavacamten treatment for hypertrophic cardiomyopathy with left ventricular outflow tract obstruction by Jane Draper, Antonio De Marvao, Robert M Cooper, Gerry Carr-White, Nabeel Sheikh, Rachel Bastiaenen, Yande Kasolo, Jason N Dungu, Edward Burford

“…Eligibility criteria included New York Heart Association (NYHA) class II–III symptoms and LVOT gradients >30 mm Hg with normal left ventricular ejection function (LVEF >55%), as per National Institute for Health and Care Excellence guidelines and product literature. …”
Get full text

The Coronary Angiography-Derived Index of Microcirculatory Resistance Predicts Left Ventricular Performance Recovery in Patients with ST-Segment Elevation Myocardial Infarction by Chang Hou, Meng Guo, Yuliang Ma, Qi Li, Chuanfen Liu, Mingyu Lu, Hong Zhao, Jian Liu

“…The post-PCI caIMR can accurately predict left ventricular functional recovery at 3 months follow-up in patients with STEMI treated by primary PCI, supporting its use in clinical practice.…”
Get full text

COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE F... by I. V. Zhirov, O. A. Nikolaeva, S. N. Tereshchenko

Get full text

Efficacy and safety of left bundle branch area pacing versus right ventricular apex pacing in patients with atrioventricular block: study protocol for a randomised controlled trial by Junjun Chen, Liting Cheng, Junmeng Zhang, Zefeng Wang, Zhuo Liang, Jieruo Chen, Yongquan Wu, Xiao Du, Ruiqing Dong, Fei Hang, Xinlu Wang, Ziyu Wang

“…A limited number of retrospective clinical studies, featuring small sample sizes, have shown that compared with right ventricular apex pacing (RVAP), the QRS duration of postoperative ECG in LBBaP patients is narrower and the cardiac systolic function is improved. …”
Get full text

Painful Left Bundle Branch Block Syndrome Treated With Conduction System Pacing. A Report of Two Cases by Catalin Pestrea, Constantin Guzgan, Ecaterina Cicala, Radu Vatasescu

“…The evolution of the patients was favorable, with the six‐month follow‐up showing complete remission of symptoms and recovery of LV function.…”
Get full text

Severe Left Ventricular Hypertrophy, Small Pericardial Effusion, and Diffuse Late Gadolinium Enhancement by Cardiac Magnetic Resonance Suspecting Cardiac Amyloidosis: Endomyocardia... by Nina P. Hofmann, Sorin Giusca, Karin Klingel, Peter Nunninger, Grigorios Korosoglou

“…The diagnostic process with LV hypertrophy requires the integration of clinical evaluation, electrocardiography (ECG), echocardiography, biochemical markers, and if required CMR and endomyocardial biopsy in order to reach the correct diagnosis. Here, we present a case of a patient with severe LV hypertrophy (septal wall thickness of 23 mm, LV mass of 264 g, and LV mass index of 147 g/m2), severely impaired longitudinal function, and preserved radial contractility (ejection fraction = 55%), accompanied by small pericardial effusion and diffuse late gadolinium enhancement (LGE) by cardiac magnetic resonance (CMR). …”
Get full text

ALCAPA Presents in an Adult with Exercise Intolerance but Preserved Cardiac Function by Yan Liu, Beth W. Miller

“…She had normal left ventricular function without apparent ischemic cardiac symptoms eighteen months after procedure.…”
Get full text

Characteristics of patients with chronic heart failure with mildly reduced ejection fraction: clinical and demographic aspect by M. T. Duishenalieva, A. G. Polupanov, F. T. Rysmatova, E. Zh. Myrzabekova, N. E. Esenbekova, N. Ch. Cholponbekova, E. Sh. Altymyshova, A. T. Arykova, N. B. Cheskidova, E. D. Djyshambaev

“…Patients with functional class III (NYHA) predominated among those with HFmrEF (54,5 %) and HFrEF (56,3 %).Conclusion. …”
Get full text

State of precision medicine for heart failure with preserved ejection fraction in a new therapeutic age by Roy Rasalam, Andrew Sindone, Gary Deed, Ralph G. Audehm, John J. Atherton

“…Two algorithms, the ‘Heavy, 2 or more Hypertensive drugs, atrial Fibrillation, Pulmonary hypertension, Elderly age >60, elevated Filling pressures’ (H2FPEF) and the ‘Heart Failure Association Pre‐test assessment, Echocardiography and natriuretic peptide, Functional testing, Final aetiology’ (HFA‐PEFF), can help to determine the likelihood of HFpEF in individuals with symptoms of HF. …”
Get full text

NEW EMPHASES ON THE STUDY OF THE PATHOGENESIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: FOCUS ON INFLAMMATORY MARKERS by O. M. Drapkina, L. O. Palatkina

“…It makes conduct active searches for new biological markers of diastolic heart function. Participation of proinflammatory cytokines, in particular GDF-15, in the process of elasticity reduction and relaxation disorders of left ventricular myocardium, may be of great importance in the development of new medical agents designed to delay the progression of CHF with preserved ejection fraction.…”
Get full text

Modern concept of diastolic heart failure by F. T. Ageev

“…The combination of classical and tissue Doppler ultrasound provides a more precise estimation of systolic and diastolic LV function. This method, in combination with natriuretic peptide level measurement, is the basis for the diagnostic algorithm of CHF with intact LVEF. …”
Get full text

New Clinical Aspects of Eplerenone Use in Clinical Practice by S. R. Gilyarevskiy, N. G. Bendeliani, M. V. Golshmid, I. M. Kuzmina

“…The main goal of this study was to evaluate the efficacy of eplerenone compared with placebo in patients with heart failure and reduced left ventricular function. In addition, experimental animal studies, which may indicate the pleiotropic effects of eplerenone in patients with vascular diseases, are presented. …”
Get full text

A case of successful conservative therapy of patient with severe heart failure caused by ischemic heart disease: case report by M. T. Beishenkulov, Z. M. Chazymova, K. R. Kaliev, A. K. Toktosunova, Y. M. Madyarova, M. Kh. Dadabaev

“…The assessed 6-minute walk test showed functional class III according to the NYHA classification.…”
Get full text

Gut microbiota dysbiosis exacerbates heart failure by the LPS-TLR4/NF-κB signalling axis: mechanistic insights and therapeutic potential of TLR4 inhibition by Chunlei Zhang, Xiaodong Teng, Qiuhang Cao, Yanyan Deng, Mo Yang, Lei Wang, Daorong Rui, Xiu Ling, Cao Wei, Yue Chen, Dasheng Lu, Hongxiang Zhang

“…By modulating this pathway, TAK-242 improves cardiac function, suggesting its potential as a therapeutic target for heart failure. …”
Get full text

When viral myocarditis meets thrombosis tendency: deep analysis of a complex case report by Qian Ding, Yun Zhang, Dongbei Li, Wenhua Liu, Jing Feng, Shuang Li, Wei Chen, Mu Guo

“…Following treatment, inflammatory markers and coagulation function improved, cardiac function recovered (LVEF increased to 53%), and the thrombus resolved. …”
Get full text

Сlinical and hemodynamic characteristics and coronary blood flow in patients with chronic coronary artery disease and type 2 diabetes by B. U. Mardanov, M. A. Kokozheva, F. B. Shukurov, B. A. Rudenko, M. N. Mamedov

“…Among group I patients, electrocardiographic signs of left ventricular hypertrophy, conduction abnormalities, accompanied by a decrease in the left ventricular ejection fraction, impaired diastolic function, and high mean pulmonary artery pressure were significantly more often detected. …”
Get full text

ANTITHROMBOTIC THERAPY IN PREVENTION OF CARDIOVASCULAR EVENTS (DEATH, ACUTE MYOCARDIAL INFARCTION, STROKE) IN PATIENTS WITH CHRONIC HEART FAILURE by N.D. Gerasimenko, M.S. Rasin

“…It has been specified, which anticoagulants or antiplatelet agents have advantages taking into account the features of the functioning of organs and systems in patients with heart failure. …”
Get full text

ECMO‐Assisted Da Vinci Robotic Surgery for Pheochromocytoma‐Induced Acute Catecholamine Cardiomyopathy: A Case Report by Qi Wang, Jiayan Xin, Xiaoqiong Cui, Liya Hu, Meng Ning, Wenqing Gao, Yingwu Liu

“…The patient was able to resume her daily activities without any residual functional impairment. This case underscores the efficacy of the synergistic application of ECMO with robotic surgery in the management of pheochromocytoma‐induced ACIC. …”
Get full text